Clairity Announces Update to NCCN Guidelines to Include AI Mammogram-Based Risk Tool to Identify Future Breast Cancer Risk in Women Missed by Traditional Met…
This image was generated by AI and may not depict real events.
The National Comprehensive Cancer Network has updated its guidelines to include an AI-based risk assessment tool for breast cancer. The tool, developed by Clairity, uses mammogram analysis to identify women at increased risk of developing breast cancer, particularly those who may not be identified through traditional methods.
The National Comprehensive Cancer Network has updated its guidelines for breast cancer screening and diagnosis. The new guidelines include a risk assessment option that uses artificial intelligence to analyze mammograms and assess future breast cancer risk. This approach can identify women at increased risk, starting at age 35. The guidelines introduce a five-year breast cancer risk threshold and recommend supplemental imaging and risk-reduction strategies for high-risk individuals. The AI-based model, developed by Clairity, is the first FDA-approved model to predict five-year breast cancer risk using mammography. The update aims to provide more personalized detection and prevention strategies for breast cancer.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.